In the second part of an exclusive interview with Cannabiz, ECS Botanics executive GM Nan-Maree Schoerie outlines the regulatory challenges facing the industry, discusses the “controlled and considered” growth of ECS and stresses the need for GPs to recognise the therapeutic benefits of cannabis.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

In a new corporate video on its website, ECS Botanics discusses its ability to move fast.

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades. He is a regulator contributor to health journal, The Medical Republic, writing on...